Hyperparathyroidism happens when the parathyroid glands make too much parathyroid hormone. This can affect your calcium levels and cause other health problems. You may have hyperparathyroidism if your ...

Impaired coronary flow reserve in patients with metastatic cancer treated with sunitinib. Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

COPENHAGEN, Denmark, May 13, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced 2-year results from a post-hoc analysis of the Company’s Phase 3 PaTHway Trial demonstrating ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Palopegteriparatide improved skeletal dynamics and renal ...

Dawn Ethier, a police officer in Ottawa, Canada, recalls how her life revolved around managing her 100-pill-a-day regimen. Her symptoms began 3 weeks after her thyroid surgery, but it took another 4 ...

COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal function ...

The well conceived clinical study of Barreras and Donaldson reported elsewhere in this issue of the Journal indicates clearly that gastric hypersecretion in a given patient can accompany long-term ...

Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study. Patient-derived parathyroid organoids (PTOs) ...

Primary hyperparathyroidism occurs when one or more of the parathyroid glands overproduce the parathyroid hormone (PTH), which causes calcium to be pulled from the bones and intestinal track and ...